Top Industry Leaders in the Hydronephrosis Market
Latest Hydronephrosis Companies Updates:
Boston Scientific acquires NxThera This December 2023 deal expands Boston Scientific's urology portfolio by adding NxThera's minimally invasive AquaLase® system for treating hydronephrosis and other urological conditions.
Siemens Healthineers collaborates with University of California, San Francisco This partnership aims to develop and commercialize AI-powered tools for early diagnosis and personalized treatment of hydronephrosis.
Olympus unveils its VERSAFO V System This versatile system combines robotic technology with advanced imaging capabilities, enabling minimally invasive and precise ureteroscopic procedures for treating hydronephrosis.
St. Jude Medical introduces its Prodigy™ Pacing System with MRI conditional labeling This pacemaker allows patients with hydronephrosis who also require cardiac pacing to undergo MRI scans safely, improving diagnosis and treatment options.
List of Hydronephrosis Key companies in the market:
- NephroGenex, Inc. (U.S)
- American Renal Associates (U.S)
- PHRAXIS, INC. (U.S)
- Renal Associates P.A. (U.S)
- ALLERGAN (U.S)
- Amgen Inc. (U.S)
- Anthem Bio Pharm (U.S)
- Sanofi (U.S)
- Novartis AG (Germany) .